Skip to content

Clinical trials

Phase 3 Muscular Dystrophy, Duchenne trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Phase: Phase 3 Country / region: Spain Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20121
20132
20141
20162
20171
20183
20204
20213
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated8
Active, not recruiting3
Recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sarepta Therapeutics, Inc.6
PTC Therapeutics3
Santhera Pharmaceuticals3
GlaxoSmithKline2
Italfarmaco2
Kyntra Bio2
NS Pharma, Inc.2
Avidity Biosciences, Inc.1
Eli Lilly and Company1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne24
Muscular Dystrophies7
Genetic Diseases, Inborn4
Muscular Diseases4
Muscular Disorders, Atrophic4
Musculoskeletal Diseases4
Nervous System Diseases4
Neuromuscular Diseases4
Genetic Diseases, X-Linked3
Infant, Newborn, Diseases1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.